Drugs Used to Treat Infections

Antimicrobial Agents

  • Types of Antimicrobial Agents:

    • Antibiotics classified by target pathogen:

      • Antibacterial: Treats bacteria.

      • Antifungal: Treats fungi.

      • Antiviral: Treats viruses.

    • Chemical Families:

      • Penicillins

      • Tetracyclines

      • Aminoglycosides

  • Culture and sensitivity tests determine the causative pathogens.

  • Other considerations for use:

    • Toxicity potential to the patient

    • Clinical judgement

    • Previous infection treatments

    • Reactions to antibiotics

Selection and Assessment

  • Choosing Antibiotics:

    • Based on pathogen sensitivity and patient toxicity considerations.

    • Utilize culture and sensitivity tests for appropriate selections.

    • Consider empirical treatment and prophylactic antibiotics for infection prevention.

Nursing Assessment
  • Before Therapy:

    • Assess current infection history & medication history.

    • Conduct a physical examination and psychosocial evaluation.

  • During Therapy:

    • Adverse Effects Monitoring:

    • Nausea, Vomiting, Diarrhea (the "big three"):

      • Assess relation to antibiotic use, hydration status, report diarrhea, abdominal pain.

    • Secondary Infections:

      • Watch for oral infections, lesions, or itching in vaginal, anal areas.

      • Can produce severe life-threatening diarrhea.

    • Allergies and Anaphylaxis:

      • Mild to fatal, within 30 minutes after administration to days after therapy.

      • Anaphylaxis, laryngeal edema, shoch, dyspnea, skin reactions.

      • Determine if allergies (skin rash, edema, dyspnea) or GI symptoms.

    • Nephrotoxicity:

      • Increasing BUN/creatinine levels, decreasing urine output, changes in UA.

    • Hepatotoxicity:

      • Check for preexisting hepatic disease, abnormal liver function tests.

    • Ototoxicity:

      • Damage to eighth cranial nerve, can lead to hearing loss

    • Blood Dyscrasias:

      • Report hematological symptoms.

  • Additional Notes:

    • Laboratory test values indicating infection: CBC, ESR, BUN, AST, ALT, GGT, C-reactive protein, electrolytes.

    • American Heart Association recommends prophylactic antibiotics for patients with certain cardiac conditions.

    • Nephrotoxicity is evidenced by increasing BUN and creatinine, decreased urine output.

    • Ototoxicity is damage to the eighth cranial nerve, primarily by aminoglycosides—hearing loss, dizziness, tinnitus.

    • Photosensitivity occurs with certain antibiotics.

Implementation Strategies

  • Patient Care During Therapy:

    • Infection Control: Ensure proper transmission precautions.

      • Secondary Infections: Notify healthcare provider if infection develops.

    • Monitor IV Therapy: Check for phlebitis and instability of medications.

    • Scheduling: Administer medications on time; clarify food interactions.

    • Hydration and Nutrition: Manage nausea and adjust medication routes if necessary.

      • Nausea, vomiting, diarrhea: Give with food if possible, or healthcare provider can switch to parenteral.

    • Monitoring Adverse Effects:

      • Nephrotoxicity: Monitor BUN/creatine, I&O; report declining urine output <30 mL/hr.

      • Hepatotoxicity: Monitor labs, observe for anorexia, nausea, vomiting, jaundice, etc.

      • Ototoxicity: Report hearing impairment, dizziness, or tinnitus.

      • Blood dyscrasias: Monitor and report sore throat, fatigue, elevated temperature, skin hemorrhages, and bruises.

    • Allergies/Anaphylaxis: Monitor patients with allergies, asthma, rhinitis, or taking multiple meds for allergic response; watch for 20 to 30 minutes after administration.

      Photosensitivity Management: Advise use of sunscreen and avoidance of UV exposure.

Patient Education

  • Key Instructions for Patients:

    • Emphasize the importance of rest, hydration, and proper nutrition.

    • Discuss personal hygiene and precautions for STI treatments.

      • Refrain from sexual intercourse during therapy for STIs.

    • Educate on common adverse effects and proper reporting.

    • Urgent need to finish the full course of antimicrobials to avoid resistance.

Drug Classes and Their Actions

  • Examples of Antibiotics:

    • Aminoglycosides:

      • Action: Inhibit protein synthesis.

      • Uses: Effective against gram-negative organisms that cause urinary infections, meningitis, wound infections, septicemia.

      • Serious Adverse Effects: Ototoxicity, nephrotoxicity.

      • Do not give within 72 hours of skeletal muscle relaxants used with anesthesia.

      • Aminoglycosides stop organisms from multiplying and spreading.

    • Carbapenems:

      • Action: Inhibit bacterial cell wall synthesis; potent broad-spectrum agents resistant to beta-lactamase enzymes secreted by bacteria.

      • Uses: Treat severe infections by multidrug-resistant organisms.

      • Adverse Effects: Hypersensitivity; severe diarrhea, if contains blood may be indication of pseudomembranous colitis; dizziness, confusion, seizures.

      • Effective against intraabdominal infections and pelvic sepsis.

      • Cilastatin is given with imipenem (Primaxin) to prevent the inactivation of imipenem by a renal enzyme.

        • Cilastatin is not an antibiotic.

    • Cephalosporins:

      • Action: Related to penicillins; inhibit bacterial cell wall synthesis; divided into groups.

      • Uses: Treats UTI, respiratory tract infections, abdominal infections, bacteremia, meningitis, osteomyelitis; ceftaroline may treat MRSA, VRSA.

      • Common Adverse Effects: Diarrhea, electrolyte imbalances.

      • Serious Adverse Effects: Secondary infections; hepatotoxicity; nephrotoxicity; hypoprothrombinemia.

      • First-generation agents are effective against gram-positive microorganisms.

      • Second- and third-generation agents have increased activity against gram-negative organisms.

      • Fourth-generation cephalosporins are broad-spectrum agents.

    • Glycopeptides:

      • Action: Prevent synthesis of bacterial cell walls.

      • Uses

        • Dalbavancin is used in treatment of adult patients with acute bacterial skin and skin structure infections.

        • Oritavancin, telavancin, vancomycin.

      • Therapeutic Outcome: Elimination of bacterial infection.

      • Serious Adverse Effects: Ototoxicity, nephrotoxicity, Q-T interval prolongation, coagulation, hepatic effects, secondary infections

    • Glycylcycline:

      • Drug: Tigecycline (Tygacil)

      • Action: Binds to 30S ribosome, preventing protein synthesis; bacteriostatic

      • Use: Treat broad-spectrum gram-positive, gram-negative, and anaerobic infections, MRSA

      • Common Adverse Effect: Gastric irritation

      • Serious Adverse Effects: Severe diarrhea; photosensitivity

      • New family of antibiotics; tigecycline first drug

      • Used in complicated skin infections (MRSA, MSSA), intraabdominal infections.

      • Do not administer to those younger than age 18 because of the interference with tooth development.

    • Macrolides

      • Action: Inhibit protein synthesis, bacteriostatic and bactericidal

      • Uses: Treat respiratory, GI tract, skin, and soft-tissue infections

      • Common Adverse Effect: Gastric irritation

      • Serious Adverse Effects: Severe diarrhea, thrombophlebitis

      • Usually the second choice when penicillins, cephalosporins, and tetracyclines are contraindicated.

    • Oxazolidinones

      • Drug: Linezolid (Zyvox)

      • Action: Inhibits protein synthesis in bacterial cells, bactericidal, and bacteriostatic.

      • Use: Treat serious or life-threatening infections caused by gram-positive organisms.

      • Common Adverse Effects: Gastric irritation, headaches.

      • Serious Adverse Effects: Severe diarrhea, bone marrow suppression, secondary infections, lactic acidosis, seizures, visual neuropathy.

      • New class of antimicrobial agents; linezolid is first drug.

      • May be used for vancomycin-resistant E. faecium (VRE), MRSA, and MSSA; effective against gram-positive organisms only.

      • Interacts with MAOIs and other serotonergic agents.

    • Penicillins

      • Action: Inhibit cell wall synthesis, penicillinase-resistant penicillins.

      • Uses: Treat middle ear infections, pneumonia, meningitis, UTIs, syphilis, gonorrhea.

      • Common Adverse Effects: Diarrhea, electrolyte imbalance

      • Serious Adverse Effects: Hepatotoxicity, nephrotoxicity, hyperkalemia, or hypernatremia.

      • Penicillinase is the enzyme that bacteria produce to destroy the antibacterial activity of penicillins.

      • May interfere with contraceptive activity of oral contraceptives.

        • Counsel patient to use additional method.

    • Quinolones:

      • Action: Subclass known as fluoroquinolones; inhibit activity of DNA gyrase, an enzyme needed for replication of bacteria.

      • Uses: Effective against gram-positive and gram-negative bacteria.

      • Common Adverse Effects: Nausea, vomiting, diarrhea, discomfort, dizziness, lightheadedness.

      • Serious Adverse Effects: Photosensitivity, rash, nephrotoxicity, neurologic effects, hepatotoxicity.

      • Should not be prescribed for patients younger than 18 years; has resulted in an increased incidence of musculoskeletal disorders.

      • Risk of musculoskeletal disorders in patients older than 60 is increased in patients using corticosteroids.

      • Animal studies have demonstrated teratogenic effects.

        • Birth defects or abnormalities.

      • Levofloxacin used with caution in older patients with long QT syndrome, hypokalemia, or taking certain antiarrhythmic medications.

    • Streptogramins

      • Drug: Quinupristin-dalfopristin (Synercid)

      • Action: Inhibits protein synthesis in bacterial cells

      • Uses: Treatment of vancomycin-resistant E. faecium (VRE), MRSA

      • Common Adverse Effects: Pain, infusion site inflammation, nausea, vomiting, diarrhea, anorexia, abdominal cramps

      • Serious Adverse Effects: Hepatotoxicity, arthralgia, myalgia

      • Numerous serious drug interactions

      • New class developed from pristinamycin

      • Important for treatment of vancomycin-resistant bacteria; reserved for cases in which other antibiotics are not effective

    • Sulfonamides:

      • Action: Inhibit biosynthesis of folic acid resulting in cell death.

      • Uses: Treats UTIs and otitis media, traveler’s diarrhea, chronic diarrhea, prevention and treatment of Pneumocystis jiroveci in immunocompromised patients.

      • Common Adverse Effects: Nausea, vomiting, diarrhea, anorexia.

      • Serious Adverse Effects:

        • Rash, pruritus, photosensitivity, hematologic reactions, neurologic CNS effects.

        • Notify prescriber if rash or pruritus develops.

        • Crystal formation in urinary tract if patient is dehydrated.

      • Work fast, usually after one or two doses.

      • Used prophylactically in patients susceptible to streptococcal infection or rhematic fever when penicillin is contraindicated.

    • Tetracyclines:

      • Action: Inhibit protein synthesis by bacterial cells.

      • Uses: Treat STIs, UTIs, upper respiratory tract infections, pneumonia, and meningitis when penicillin is contraindicated.

      • Common Adverse Effects: Nausea, vomiting, diarrhea, anorexia, abdominal cramps, diarrhea.

      • Serious Adverse Effect: Photosensitivity.

      • Can stain teeth; not recommended for children younger than age 8 or pregnant women.

  • Miscellaneous Antibiotics:

    • Aztreonam (Azactam): Inhibits cell wall synthesis, monobactams

    • Clindamycin (Cleocin): Inhibits protein synthesis

    • Daptomycin (Cubicin)

      • Cyclic lipopeptide, binds to bacterial membranes and causes rapid depolarization

      • Serious adverse effects: diarrhea, muscle pain

      • Used only for cases of vancomycin resistance; may also cause skeletal muscle weakness and pain.

    • Metronidazole (Flagyl): Bactericidal, trichomonacidal, and protozoacidal activity

    • Tinidazole (Tindamax)

      • Similar to metronidazole

      • Primary therapeutic outcome: elimination of parasitic infection

Antitubercular Agents

  • Drug: Ethambutol (Myambutol)

    • Action: Alter cellular RNA synthesis and phosphate metabolism

    • Use: Treatment of tuberculosis

    • Common Adverse Effects: Nausea, vomiting, anorexia, abdominal cramps

    • Serious Adverse Effects: Confusion, hallucination, blurred vision, red-green vision changes

    • Major problem with toxicity can occur.

    • Treatment can last 6 months.

  • Drug: Isoniazid (INH, Nydrazid)

    • Action: Disrupts the cell wall and inhibits replication of tuberculosis bacteria

    • Use: Treats and prevents tuberculosis

    • Common Adverse Effects: Nausea, vomiting

    • Serious Adverse Effects: Hepatotoxicity, tingling, numbness of hands and feet, dizziness, ataxia

    • Adverse effects are dose related; concurrent use of pyridoxine usually prevent symptoms.

  • Drug: Rifampin (Rifadin)

    • Action: Prevents RNA synthesis by inhibiting DNA-dependent RNA polymerase

    • Use: Eliminates meningococci and H. influenzae type b (Hib) from asymptomatic carriers

    • Common Adverse Effect: Reddish-orange secretions

    • Serious Adverse Effects: Nausea, vomiting, anorexia, abdominal cramps

    • Also used in combination with other agents to treat tuberculosis.

  • All three medications (ethambutol, isoniazid, rifampin) must be used in combination to prevent resistant organisms.

  • Drug: Pyrazinamide (Tebrazid)

    • Action: Lowers the pH of environment

    • Use: Treatment of tuberculosis; in combination with antitubercular agents

    • Common Adverse Effects: Nausea, vomiting, anorexia, arthralgia, myalgia

    • Serious Adverse Effect: Hepatotoxicity

    • Contraindicated in patients with acute gout.

Antifungal Agents

  • Topical Antifungal Agents

    • Action: Alter permeability of cell membranes, causing amino acids and electrolytes to leak out

    • Uses: Treat tinea pedis, tinea cruris, tinea corporis, tinea versicolor, Candida infections

    • Common and Serious Adverse Effects: Irritation, redness, swelling, blistering, oozing

    • Watch for secondary skin rashes

  • Systemic Antifungal Agents

    • Drug: Amphotericin B

      • Action: Fungistatic agent; disrupts cell membrane of fungal cells

      • Use: Treatment of systemic life-threatening fungal infection

      • Common Adverse Effects: Malaise, fever, chills, headache, nausea, vomiting, thrombophlebitis

      • Serious Adverse Effects: Nephrotoxicity, electrolyte imbalance

      • Dosage Forms: Amphotericin B with or without sodium desoxycholate (Fungizone IV), amphotericin B cholesteryl sulfate complex (Amphotec), amphotericin B lipid complex (Abelcet), amphotericin B liposomal (AmBisome).

      • Should not be used for noninvasive fungal infections such as thrush, vaginal candidiasis, esophageal candidiasis.

    • Drug: Fluconazole (Diflucan)

      • Action: Chemically related to ketoconazole and itraconazole; inhibits certain metabolic pathways in fungi

      • Uses: Treatment of meningitis, candidiasis, systemic candidiasis

      • Common Adverse Effects: Nausea, vomiting, diarrhea

      • Serious Adverse Effects: Rash, hepatotoxicity

      • Administered via IV and oral routes.

    • Drug: Griseofulvin microsize (Griseofulvin ultramicrosize, Grifulvin V)

      • Action: Stops cell division and new cell growth

      • Use: Treatment of ringworm

      • Common Adverse Effects: Nausea, vomiting, abdominal cramps

      • Serious Adverse Effects: Urticaria, rash, pruritus; photosensitivity; confusion, dizziness, secondary infections, nephrotoxicity, hepatotoxicity, hematologic

      • Available orally only

      • Treatment often required for several months

    • Drug: Itraconazole (Sporanox)

      • Action: Chemically related to fluconazole and ketoconazole; interferes with cell wall synthesis

      • Uses: Treatment of variety of infections such as candidiasis, histoplasmosis, blastomycosis

      • Common Adverse Effects: Nausea, vomiting

      • Serious Adverse Effects: Hepatotoxicity; heart failure; pruritus, rash

      • Numerous serious drug interactions

      • Do not administer to patients with a history of heart failure; has negative inotropic properties.

      • Has many drug interactions because it is a potent inhibitor of metabolizing enzymes in the liver.

    • Drug: Terbinafine (Lamisil)

      • Action: Inhibits squalene epoxidase, a key enzyme required for biosynthesis in fungi

      • Use: Treatment of onychomycosis of the toenail or fingernail

      • Serious adverse effects: Pruritus, rash, fever, chills; nephrotoxicity, hepatotoxicity; neutropenia, lymphopenia

Antiviral Agents

  • Drug: Acyclovir (Zovirax)

    • Action: Inhibits viral cell replication

    • Uses: Topically used to treat herpes genitalis; orally used to treat recurrent genital herpes; IV to treat herpes simplex types 1 and 2 in immunosuppressed patients

    • Serious Adverse Effects: Pruritus, rash, burning, hives, diaphoresis, nephrotoxicity, hypotension, confusion

    • Cautions with topical use to avoid spread

  • Drug: Famciclovir (Famvir)

    • Action: Prodrug of penciclovir; inhibits viral cell replication

    • Uses: Treatment of recurrent infections of genital herpes, acute herpes zoster

    • Common Adverse Effects: Nausea, vomiting, headache

    • Serious Adverse Effect: Confusion

  • Drug: Oseltamivir (Tamiflu)

    • Action: Inhibits neuraminidase

    • Use: Treats uncomplicated acute illness caused by influenza

    • Common Adverse Effects: Nausea, vomiting, cough, sore throat, fever, continuing symptoms

  • Drug: Ribavirin (Virazole, Rebetol, Ribasphere)

    • Action: Unknown

    • Uses: In combination with interferon alpha-2b to treat chronic hepatitis C, effective against DNA type viral families, inhibitory activity against RSV, influenza, parainfluenza

    • Common Adverse Effects: Rash, conjunctivitis

    • Serious Adverse Effects: Diminishing pulmonary function, anemia

    • Special technique for mixing and administering breathing treatment

    • Virazole is in aerosol form; Rebetol is in oral capsule and suspension form; Ribasphere is in oral tablets and capsules

  • Drug: Valacyclovir (Valtrex)

    • Action: Inhibits viral cell replication

    • Uses: Treats acute herpes zoster (shingles) and herpes labialis (cold sores and genital herpes)

    • Therapeutic Outcome: Elimination of symptoms of viral infection

    • Valacyclovir is a prodrug of acyclovir

  • Drug: Zanamivir (Relenza)

    • Action: Inhibits neuraminidase, an enzyme on the viral cell coat necessary for replication

    • Use: Uncomplicated acute illness from influenza

    • Serious Adverse Effects: Asthma, bronchospasm, diminishing pulmonary function, cough, sore throat, fever, continuing symptoms